Efficacy trials focusing on powdery mildew in cucumber and leaf mould in tomatoes and residue trials in summerfruit are among further work approved for the final season of A Lighter Touch.
The two efficacy trials and five residue trials are in addition to the seven efficacy trials already approved in August.
One efficacy trial will evaluate selected biological and soft fungicides for powdery mildew control in greenhouse cucumbers, while another will evaluate innovative fungicides for tomato leaf mould control in greenhouse tomatoes, both priority diseases in the commercial covered cropping industry.

Covered crop diseases, powdery mildew in cucumber and leaf mould in tomatoes, are the subjects to be explored in more approved trials.
In stonefruit, a set of residue trials will be conducted to support the use of an insecticide for the management of key insect pests in stonefruit crops, including cherry, apricot, peach and nectarine. The residue data is important for SNZ’s residue assurance programme that ensures that crop protection product use complies with all export residue limits.
This builds on previous work under the ALT-Summerfruit NZ programme, and will further expand access to reduced-risk crop protection products.
With ALT ending in March 2027, this upcoming summer of trials will be the last undertaken as a part of the programme. ALT technical lead Bruno Gatimel says to date, 121 products have been evaluated across 84 efficacy and residue trials, of which 48 were biological solutions, 72 softer chemistry and two were physical products.
“ALT trials have enabled the identification of several high-performing products with potential practical value for growers.”
Data gathered through efficacy and residue trials undertaken through the ALT programme supports access to innovative crop protection products for growers and their industries. For products to achieve registration or a new label claim through the regulatory process, robust data and multiple sets of data are required, including several seasons of New Zealand trial results.

